We discovered that N6-methyladenosine (m6A) modulators-specifically YTHDF3, YTHDC1, and METTL14-cooperatively upregulate BGN expression in a parallel, non-hierarchical manner converging on functional m6A sites within melanoma cells. Here, METTL14 is linked to melanoma.